ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
1 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
1.6K
|
492K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
Speckled
|
2.0K |
1.0M |
3 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
2.0K
|
1.0M
|
3
|
|
ASX - By Stock
|
OCC |
Re:
FDA significance
|
|
Speckled
|
502 |
302K |
5 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
502
|
302K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Successful Rotator Cuff Regeneration Publication
|
|
Speckled
|
60 |
16K |
2 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
60
|
16K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Proposed issue of Securities - OCC
|
|
Speckled
|
16 |
6.1K |
4 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
16
|
6.1K
|
4
|
|
ASX - By Stock
|
NAB |
Re:
Ann: NAB advised of referral to AUSTRAC Enforcement Team
|
|
Speckled
|
22 |
12K |
8 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
22
|
12K
|
8
|
|
ASX - By Stock
|
NAB |
Re:
Ann: NAB advised of referral to AUSTRAC Enforcement Team
|
|
Speckled
|
22 |
12K |
7 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
22
|
12K
|
7
|
|
ASX - By Stock
|
NAB |
Re:
Ann: NAB advised of referral to AUSTRAC Enforcement Team
|
|
Speckled
|
22 |
12K |
8 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
22
|
12K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
Speckled
|
2.0K |
1.0M |
6 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
2.0K
|
1.0M
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: New Collagen Rope Patent for CelGro Platform Technology
|
|
Speckled
|
90 |
22K |
5 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
90
|
22K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: New Collagen Rope Patent for CelGro Platform Technology
|
|
Speckled
|
90 |
22K |
3 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
90
|
22K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: New Collagen Rope Patent for CelGro Platform Technology
|
|
Speckled
|
90 |
22K |
3 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
90
|
22K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: New Collagen Rope Patent for CelGro Platform Technology
|
|
Speckled
|
90 |
22K |
1 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
90
|
22K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: New Collagen Rope Patent for CelGro Platform Technology
|
|
Speckled
|
90 |
22K |
10 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
90
|
22K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: New Collagen Rope Patent for CelGro Platform Technology
|
|
Speckled
|
90 |
22K |
5 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
90
|
22K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
2 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
1.6K
|
492K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
5 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
143
|
35K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
0 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
143
|
35K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
4 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
143
|
35K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
2 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
143
|
35K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
1 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
143
|
35K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
1 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
143
|
35K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
6 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
143
|
35K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
4 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
143
|
35K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
2 |
16/05/21 |
16/05/21 |
ASX - By Stock
|
143
|
35K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
2 |
15/05/21 |
15/05/21 |
ASX - By Stock
|
143
|
35K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 2A and Notice Under Section 708A
|
|
Speckled
|
6 |
1.7K |
0 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
6
|
1.7K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
4 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
143
|
35K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
1 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
143
|
35K
|
1
|
|
ASX - By Stock
|
XRO |
Re:
News: XRO Xero Reports FY Net Profit Of NZ$19.8 Mln
|
|
Speckled
|
40 |
21K |
2 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
40
|
21K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Further CelGro® nerve clinical trial data from all patients at 12 months
|
|
Speckled
|
143 |
35K |
7 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
143
|
35K
|
7
|
|
ASX - By Stock
|
XRO |
Re:
News: XRO Xero Reports FY Net Profit Of NZ$19.8 Mln
|
|
Speckled
|
40 |
21K |
4 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
40
|
21K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
when will this go up?!
|
|
Speckled
|
17 |
5.8K |
7 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
17
|
5.8K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
when will this go up?!
|
|
Speckled
|
17 |
5.8K |
5 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
17
|
5.8K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
when will this go up?!
|
|
Speckled
|
17 |
5.8K |
8 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
17
|
5.8K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
2 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
218
|
68K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Speckled
|
15 |
4.7K |
4 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
15
|
4.7K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro Study Results Open Up New US Market Access Strategy
|
|
Speckled
|
85 |
20K |
13 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
85
|
20K
|
13
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
2 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
218
|
68K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
Speckled
|
2.0K |
1.0M |
4 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
2.0K
|
1.0M
|
4
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
10 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
1.6K
|
492K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
3 |
11/04/21 |
11/04/21 |
ASX - By Stock
|
1.6K
|
492K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
2 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
1.6K
|
492K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Remplir™ and SMRT GRAFT™
|
|
Speckled
|
19 |
4.8K |
4 |
05/04/21 |
05/04/21 |
ASX - By Stock
|
19
|
4.8K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
2 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
1.6K
|
492K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
Speckled
|
458 |
152K |
7 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
458
|
152K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
Speckled
|
2.0K |
1.0M |
5 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
2.0K
|
1.0M
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
1 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
1.6K
|
492K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
2 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
1.6K
|
492K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
2 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
1.6K
|
492K
|
2
|
|